SEC 13F Intelligence

Norges Bank / CELG

Norges Bank’s Celgene Corp Position

Does Norges Bank own Celgene Corp (CELG)? Not currently — the last reported position was 7.88M shares worth $783M in Q3 2019; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$783M
Q3 2019
Shares
7.88M
% of Portfolio
+0.24%
Quarters Held
7
position exited

Position History CELG

Reported value by quarter
Q1 ’18: $645MQ1 ’18Q2 ’18: $576MQ2 ’18Q3 ’18: $684MQ3 ’18Q4 ’18: $484MQ4 ’18Q1 ’19: $718MQ1 ’19Q2 ’19: $753MQ2 ’19Q3 ’19: $783MQ3 ’19filingsflow.com
QuarterSharesValue% of Portfolio
Q3 20197.88M$783M+0.24%
Q2 20198.14M$753M+0.23%
Q1 20197.61M$718M+0.23%
Q4 20187.56M$484M+0.18%
Q3 20187.64M$684M+0.22%
Q2 20187.25M$576M+0.20%
Q1 20187.23M$645M+0.23%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Norges Bank’s full portfolio or all institutional holders of CELG.